life science investing Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
